Tessa Forbes

Tessa Forbes is Director of Clinical Operations at CoA Therapeutics. Tessa has worked in the biotech industry for 20+ years in a wide range of therapeutic areas and in all stages of clinical development. She has worked on the CRO side, including experience at Parexel, Quintiles, and ProTrials, and at sponsor companies including CV Therapeutics, Medivation, and most recently BioMarin. She discovered her passion for working on rare disease programs while working at BioMarin where she led a global team for an enzyme replacement therapy for Batten Disease patients. Tessa brings this enthusiasm and experience to CoA Therapeutics, where each day is focused on working quickly and diligently on potential treatments for patients and their families. She received her undergraduate degree in Psychology from the University of Massachusetts at Amherst and her Master of Public Health degree from Johns Hopkins.